CXCL5 and colorectal carcinoma: Performer studies showed that CXCL5 induces EMT to promote CRC cell migration via activating ERK/Elk-1/Snail, and enhances infiltration by activating AKT/GSK3β, thereby inhibiting β-catenin degradation (Zhao et al., 2017).